Home Report Store Biopharmaceutical Processing Equipment and Consumables Market

Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031

Report ID:MRHC - 10458 Pages: 294 Aug-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 Hours

The Biopharmaceutical Processing Equipment and Consumables Market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.

Biopharmaceutical Processing Equipment and Consumables Market Size & Forecast

The growth of this market is driven by the growing biopharmaceuticals market, biopharmaceutical plant capacity expansions, and the rising adoption of single-use bioprocessing equipment. Furthermore, emerging economies, the shift toward bioprocessing 4.0, and the rising adoption of personalized medicines are expected to generate growth opportunities for the stakeholders in this market.

Biopharmaceutical Processing Equipment and Consumables Market Growth Drivers

Growing Adoption of Single-use Bioprocessing Equipment for Commercial Production

For many years, the biopharmaceutical processing industry has been dominated by stainless-steel/reusable equipment. The majority of biopharmaceutical manufacturing facilities contain fixed mixers, bioprocessing vessels, and bioreactors made of stainless steel. However, in recent years, the tendency has shifted in favor of single-use/disposable equipment adoption. This is explained by the equipment's many benefits over traditional stainless-steel equipment, including lower manufacturing costs (due to the elimination of cleaning and validation stages).

Besides reducing the time and labor required, single-use technologies also help reduce capital costs and energy consumption, improving efficiency. Single-use systems have a lower carbon footprint than permanent steel systems, despite producing waste from the burning and disposal of plastic materials. There is significantly more carbon dioxide released during the steam-in-place sterilization of stainless-steel vessels, pipes, and other hardware, and during the steam-generation process for water for injection (WFI) cleaning than there is during the production and disposal of single-use plastic systems.

Thus, incorporating single-use platforms significantly reduces the usage of WFI, steam, and cleaning agents.

Biopharmaceutical Processing Equipment and Consumables Market

Click here to: Get Free Sample Pages of this Report

Capacity Expansions of Biopharmaceutical Plants

Biosimilars and biologics are gaining significant importance in oncology, autoimmune diseases, and rare diseases. To meet the growing demand for biopharmaceuticals, several manufacturers are expanding their manufacturing facilities. These capacity expansions from biopharmaceutical manufacturers and CDMOs will generate additional demand for biopharmaceutical manufacturing equipment and consumables and thereby propel market growth. Some of the instances for biopharmaceutical plants capacity include:

In January 2024, AbbVie Inc. (U.S.) expanded its biologics manufacturing facility in Singapore with an investment of USD 223 million.
In November 2023, Eli Lilly and Company (U.S.) opened a new facility, with an investment of USD 2.5 billion for the capacity of the company’s parenteral (injectable) product.

Biopharmaceutical Processing Equipment and Consumables Market Trends

Growing Focus on Continuous Bioprocessing

The batch/fed-batch method has long dominated the production of biopharmaceuticals. It is not without limits, but as compared to continuous bioprocessing, it has higher operating costs and necessitates additional instruments for feedback control. Unlike batch culture, which produces a specific quantity of product in a discrete volume during the same cycle of manufacture, continuous bioprocessing involves processing the intermediate or final product at a specific location without interruption due to a continuous flow of raw materials into and out of the bioreactor. The procedure is usually broken down into numerous discrete parts, many of which are carried out at various locations. Additionally, continuous processing produces a high-quality final product that is uniform in providing lower capital costs, improving process flow, smaller equipment size, and steady-state operation.

Due to the growing demand for innovative and complex therapies and the increasing competition in the biopharmaceuticals market, biopharmaceutical manufacturers are reconsidering manufacturing methods (shifting from batch to continuous manufacturing). Although batch manufacturing is the most preferred method, continuous manufacturing is increasingly accepted in the pharmaceutical industry due to its commercial advantages.

Strong R&D Pipeline of Biopharmaceuticals

At present, antibody-based biopharmaceuticals are dominating the market. There is a large number of antibody-based biopharmaceuticals present in the clinical pipeline of various biopharmaceutical companies. Twenty-one experimental antibody treatments are undergoing regulatory review in the United States and the European Union as of January 10, 2021, according to statistics given by The Antibody Society, an international non-profit research and development organization focused on antibodies. In the United States or the European Union, thirteen antibody medicines received initial approvals between January 1, 2021, and December 31, 2021. Moreover, fifty-five innovative medications and biological products were approved by the Center for Drug Evaluation and Research (CDER) in 2023.

Thus, with more biopharmaceuticals entering a commercial stage, the demand for bioprocessing equipment and consumables used in their production is expected to grow.

Biopharmaceutical Processing Equipment and Consumables Market Opportunities

Shift Towards Bioprocessing 4.0

The rapid development in emerging economies, progressing research in biologics, and the growing penetration of biopharmaceuticals have created tremendous opportunities for biopharmaceutical manufacturers, boosting the demand for biopharmaceutical processing equipment and consumables. The manufacturing of biologics has grown over the last few years. The industry is shifting towards Bioprocessing 4.0, a term derived from Industry 4.0, which is a national strategic initiative launched by the German government in 2010. The era of biomanufacturing 4.0 is still young. An end-to-end connected bioprocess, or bioprocessing 4.0, is characterized by all systems and equipment being digitally connected to form the Industrial Internet of Things (IoT), which allows the process to be run, controlled, and improved through artificial intelligence (AI) and machine learning.

Biopharmaceutical Processing Equipment and Consumables Market Analysis: Key Findings

By Product Type: In 2024, the Filtration Segment is Expected to Dominate the Biopharmaceutical Processing Equipment and Consumables Market

Based on product type, the global biopharmaceutical processing equipment and consumables market is segmented into filtration systems, chromatography equipment and consumables, bioreactors, cell culture products, mixers/mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, shakers, biosafety cabinets, and other consumables and accessories. In 2024, the filtration systems segment is estimated to account for the largest share of 22.3% of the global biopharmaceutical processing equipment and consumables market. The large share of this segment is attributed to the recurring use of filtration at every step in bioprocessing and technological advancements in filtration technologies.

Filtration is a basic requisite across all stages of bioproduction. It is commonly used in biopharmaceutical processing to separate components. It is also used in various downstream operations, such as clarification, filtration of intermediates, critical final filling applications, or upstream processing for sterilizing-grade filtration of cell culture media.

However, the bioreactors segment is expected to grow at the highest CAGR of 17.1% during the forecast period of 2024 to 2031. The accelerated development of biopharmaceuticals for therapeutic indications like cancer, rare diseases, and infectious diseases; new product developments; and the growing deployment of single-use bioprocessing technologies are the factors driving the growth of the bioreactors segment.

Bioreactors, also called fermenters, are containers that provide an ideal environment for enzymes or whole cells to transform biochemicals into products. Bioreactors are used for many applications, including cell growth, enzyme production, biocatalysis, tissue engineering, algae production, protein synthesis, and anaerobic digestion. According to the Pharmaceutical Research and Manufacturers of America (PhRMA) (U.S.), currently, there are over 8,000 medicines in development, out of which 74% are potential first-in-class indicators for cancer, cardiovascular disorders, diabetes, Alzheimer’s disease, and rare diseases. As bioreactors are essential for the manufacturing of biopharmaceuticals, the growing development of biologics and biosimilars drives the segment growth during the forecast period.

By Application: In 2024, the Commercial Bioproduction Segment is Expected to Dominate the Biopharmaceutical Processing Equipment and Consumables Market

Based on application, the global biopharmaceutical processing equipment and consumables market is segmented into commercial bioproduction and research bioproduction. In 2024, The commercial bioproduction segment is estimated to account for the larger share of 77.5% of the global biopharmaceutical processing equipment and consumables market.

Growing initiatives supporting the adoption of biopharmaceuticals, rising biopharmaceutical manufacturing outsourcing, and accelerated developments in personalized therapies are likely to enhance the demand for bioprocessing equipment and consumables for the commercial bioproduction of monoclonal antibodies (mAbs), vaccines, gene therapies, and recombinant protein-based therapies.

A large number of pharmaceutical companies and contract manufacturing organizations (CMOs) involved in the manufacturing of biopharmaceuticals are witnessing high demand to produce biopharmaceuticals. In order to cater to the increasing demand, they are expanding their present manufacturing capacities, which would further increase the demand for biopharmaceutical equipment and consumables for commercial bioproduction during the forecast period. Besides this, the growing prevalence of various chronic & infectious diseases and regulatory reforms favoring the adoption of biosimilars are expected to drive the growth of the commercial bioproduction segment at the highest CAGR of 10.1% during the forecast period of 2024 to 2031.

By End User: In 2024, the Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Account for the Largest Share of the Biopharmaceutical Processing Equipment and Consumables Market

Based on end-user, the global biopharmaceutical processing equipment and consumables market is categorized into pharmaceutical & biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutes. In 2024, the pharmaceutical and biopharmaceutical companies segment is estimated to account for the largest share of the market.

The largest market share is attributable to the capacity expansion of biopharmaceutical manufacturers and the growing adoption of biopharmaceutical processing equipment for bioproduction. Biopharmaceuticals account for nearly 25% of the pharmaceutical market, and the development and manufacturing of biopharmaceuticals are gaining pace. Thus, the growing manufacturing of biopharmaceuticals by biopharmaceutical companies contributes to the large segment share.

However, the contract development and manufacturing organizations (CDMO) segment is expected to grow with the highest CAGR during the forecast period of 2024 to 2031. The growth of the segment is attributed to the growing preference of pharmaceutical and biopharmaceutical companies to outsource development and manufacturing to CDMOs due to the cost, operational, and regulatory advantages offered by CDMOs.

Biopharmaceutical Processing Equipment and Consumables Market Geographical Analysis

In 2024, Europe is estimated to account for the largest share of 33.5% of the global biopharmaceutical processing equipment and consumables market. The large share of Europe in the biopharmaceutical processing equipment and consumables market is primarily attributed to the presence of leading biopharmaceutical manufacturers in the region, growing exports from Switzerland and Denmark, and the expansion of biopharmaceutical companies. Additionally, rising production capacities of the vaccine manufacturing plants, to meet the growing demand for COVID-19 vaccines has also contributed to the largest market.

However, Asia-Pacific is expected to grow at the highest CAGR of 12.6% during the forecast period. This market's growth is attributed to factors like the increasing outsourcing of biopharmaceutical manufacturing in countries like China, India, Singapore, and South Korea; rising public & private initiatives to boost biotechnology research for the development of novel treatments for chronic diseases; and growing initiatives supporting the adoption of biopharmaceuticals. Furthermore, growing awareness of personalized medicines and the development of biotechnology incubators are also accelerating the market growth.

Key Companies

The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years. The key players profiled in the global biopharmaceutical processing equipment and consumables market report are 3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

Biopharmaceutical Processing Equipment and Consumables Industry Overview: Latest Developments from Key Industry Players

In April 2023, Cytiva (U.S.) launched X-platform bioreactors to streamline the single-use upstream bioprocessing operations.
In May 2024, Waters Corporation (U.S.) introduced the next-generation Alliance iS Bio HPLC System to increase the efficiency of quality control biopharmaceutical labs and reduce errors.
In September 2023, Getinge AB (Sweden) launched AppliFlex ST GMP, a single-use bioreactor, to increase the efficiency of research and clinical production in cell and gene therapy and mRNA production.

Biopharmaceutical Processing Equipment and Consumables Market Research Summary

Particulars	Details
Number of Pages	294
Format	PDF
Forecast Period	2024–2031
Base Year	2023
CAGR (Value)	9.5%
Market Size (Value)	USD 75.72 Billion by 2031
Segments Covered	By Product Type Filtration Systems Chromatography Equipment and Consumables Chromatography Consumables Chromatography Equipment Bioreactors Single-use Bioreactors Reusable Bioreactors Cell Culture Products Cell Culture Media Cell Culture Media, by Physical Form Dry Powder Media Liquid Media Cell Culture Media, by Type Off-the-Shelf Media Custom Media Cell Culture Media, by Source Chemically Defined Media Natural Media Reagents and Supplements Cell and Cell Lines Serum Mixing Systems Bioprocessing Containers Sterilizers Centrifuges Incubators Shakers Biosafety Cabinets Other Equipment and Consumables Support Services (Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors.) By Application Commercial Bioproduction Vaccine Manufacturing mAb Production Recombinant Protein Production Cell and Gene Therapy Production Research Bioproduction By End User Pharmaceutical & Biopharmaceutical Companies Contract Development and Manufacturing Organizations (CDMOs) Academic & Research Institutes
Countries Covered	North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Belgium, Ireland, Denmark, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America, and Middle East & Africa
Key Companies	3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).).

Key questions answered in the biopharmaceutical processing equipment and consumables market report:

What is the focus of the global biopharmaceutical processing equipment and consumables market?

This study offers a detailed assessment of the biopharmaceutical processing equipment and consumables market, including the market size & forecast for various segmentations like product type, application, and end user. The biopharmaceutical processing equipment and consumables market studied in this report also involves the value analysis of various segments and subsegments of biopharmaceutical processing equipment and consumables at regional and country levels.

What is the value of revenue generated from biopharmaceutical processing equipment and consumables across the globe? At what rate is their demand expected to grow for the next 5-7 years?

The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.

Based on product type, which biopharmaceutical processing equipment and consumables segment is estimated to hold the major share of the market?

In 2024, the filtration systems segment is estimated to account for the largest share, 22.3%, of the global biopharmaceutical processing equipment and consumables market. This segment's large share is attributed to the recurring use of filtration at every step in bioprocessing and technological advancements in filtration technologies.

Which application segment is expected to grow at the highest CAGR during the forecast period?

Based on application, the commercial bioproduction segment is expected to grow at the highest CAGR over the forecast period. A large number of biopharmaceuticals in clinical development and nearing patent expirations of biologics are the key factors supporting the market growth.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the global biopharmaceutical processing equipment and consumables market?

The growth of this market is mainly attributed to the global initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical plants, and the growing adoption of single-use bioprocessing equipment and consumables. Moreover, emerging economies, the shift towards bioprocessing 4.0, and the rising adoption of personalized medicines offer significant opportunities for market growth.

Who are the major players operating in the global biopharmaceutical processing equipment and consumables market?

The key players profiled in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

Which regions/countries are expected to offer significant growth opportunities for the market players operating in the global biopharmaceutical processing equipment and consumables market?

Emerging economies like China and India are projected to offer significant growth opportunities to the market players due to the growing outsourcing of biopharmaceutical development and manufacturing, favorable government initiatives to support biopharmaceutical manufacturing, and public and private initiatives to support pharmaceutical and biopharmaceutical growth.

Enquire

Check Discount

COVID-19

This report provides pre & post COVID-19 market estimates.

Download sample here

Related Tag: Biopharmaceutical Processing Equipment and Consumables Market Biopharmaceuticals Manufacturing Biopharmaceutical Processing Biosimilars Processing Commercial Bioproduction Research Bioproduction Processing Equipment and Consumables Antibody Production Biomanufacturing Biologics Manufacturing

Processing & Packaging Technologies

Healthcare

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Size and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Drivers
4.2.1.1. Growing Biopharmaceuticals Market
4.2.1.1.1. Rising Adoption of Biopharmaceuticals
4.2.1.1.2. Strong R&D Pipeline for Biopharmaceuticals
4.2.1.1.3. Government Initiatives
4.2.1.2. Biopharmaceutical Plant Capacity Expansions
4.2.1.3. Rising Adoption of Single-use Bioprocessing Equipment
4.2.2. Restraints
4.2.2.1. Complexities in the Development & Manufacturing of Biopharmaceuticals
4.2.3. Opportunities
4.2.3.1. Emerging Economies
4.2.3.2. Shift Toward Bioprocessing 4.0
4.2.3.3. Rising Adoption of Personalized Medicines
4.2.4. Challenges
4.2.4.1. Intensive Capital Requirements for Biopharmaceutical Production
4.3. Market Trends
4.3.1. Use of Disposable Processing Equipment for Commercial Production
4.3.2. Rising Focus on Continuous Bioprocessing
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. Japan
4.4.3.2. China
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East & Africa
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition

5. Global Biopharmaceutical Processing Equipment and Consumables Market—by Product Type
5.1. Overview
5.2. Filtration Systems
5.3. Chromatography Equipment and Consumables
5.3.1. Chromatography Consumables
5.3.2. Chromatography Equipment
5.4. Bioreactors
5.4.1. Single-use Bioreactors
5.4.2. Reusable Bioreactors
5.5. Cell Culture Products
5.5.1. Cell Culture Media
5.5.1.1. Cell Culture Media, by Physical Form
5.5.1.1.1. Dry Powder Media
5.5.1.1.2. Liquid Media
5.5.1.2. Cell Culture Media, by Type
5.5.1.2.1. Off-the-Shelf Media
5.5.1.2.2. Custom Media
5.5.1.3. Cell Culture Media, by Source
5.5.1.3.1. Chemically Defined Media
5.5.1.3.2. Natural Media
5.5.2. Reagents and Supplements
5.5.3. Cells and Cell Lines
5.5.4. Cell Culture Serum
5.6. Bioprocessing Containers (BPC)
5.7. Sterilizers
5.8. Mixers/Mixing Systems
5.9. Incubators
5.10. Centrifuges
5.11. Shakers
5.12. Biosafety Cabinets
5.13. Other Consumables and Accessories
5.14. Support Services

6. Biopharmaceutical Processing Equipment and Consumables Market—by Application
6.1. Overview
6.2. Commercial Bioproduction
6.2.1. Monoclonal Antibody Production
6.2.2. Therapeutic Protein Production
6.2.3. Vaccine Production
6.2.4. Cell and Gene Therapy
6.3. Research Bioproduction

7. Biopharmaceutical Processing Equipment & Consumables Market—by End User
7.1. Overview
7.2. Pharmaceutical & Biopharmaceutical Companies
7.3. Contract Development and Manufacturing Organizations (CDMO)
7.4. Academic & Research Institutes

8. Biopharmaceutical Processing Equipment and Consumables Market—by Geography
8.1. Overview
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. U.K.
8.2.4. Italy
8.2.5. Spain
8.2.6. Ireland
8.2.7. Denmark
8.2.8. Belgium
8.2.9. Switzerland
8.2.10. Rest of Europe
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa

9. Competitive Landscape
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis
9.5.1. Danaher Corporation (U.S.)
9.5.2. Thermo Fisher Scientific Inc. (U.S.)
9.5.3. Sartorius AG (Germany)
9.5.4. Agilent Technologies, Inc (U.S.)

10. Company Profiles
10.1. Thermo Fisher Scientific Inc.
10.2. Agilent Technologies, Inc.
10.3. Sartorius AG
10.4. Danaher Corporation
10.5. Merck KGaA
10.6. 3M Company
10.7. Bio-Rad Laboratories, Inc.
10.8. Eppendorf SE
10.9. Solaris Biotechnology Srl
10.10. Repligen Corporation

11. Appendix
11.1. Available Customization
11.2. Related Reports

List of Tables
Table 1   Recent Biopharmaceutical Plant Capacity Expansions
Table 2   U.S.: Key FDA Regulations for the Biopharmaceutical Industry
Table 3   India: Laws Regulating the Biopharmaceutical Processing Industry
Table 4   Pricing Analysis: Biopharmaceutical Processing Equipment
Table 5   Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 6   Global Filtration Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 7   Global Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 8   Global Chromatography Equipment and Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 9   Types of Chromatography Resins
Table 10   Global Chromatography Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 11   Global Chromatography Equipment Market, by Country/Region, 2022–2031(USD Million)
Table 12   Global Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 13   Global Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 14   Global Single-Use Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 15   Global Reusable Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 16   Global Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 17   Global Cell Culture Products Market, by Country/Region, 2022–2031 (USD Million)
Table 18   Global Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 19   Global Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 20   Global Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 21   Global Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 22   Global Dry Powder Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 23   Global Liquid Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 24   Global Off-The-Shelf Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 25   Global Custom Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 26   Global Chemically Defined Cell Culture Media Market, by Country/Region,2022–2031 (USD Million)
Table 27   Global Natural Media Market, by Country/Region, 2022–2031 (USD Million)
Table 28   Global Cell Culture Reagents and Supplements Market, by Country/ Region, 2022–2031 (USD Million)
Table 29   Global Cells and Cell Lines Market, by Country/Region, 2022–2031 (USD Million)
Table 30   Global Cell Culture Serum Market, by Country/Region, 2022–2031 (USD Million)
Table 31   Global Bioprocessing Containers Market, by Country/Region, 2022–2031 (USD Million)
Table 32   Global Sterilizers Market, by Country/Region, 2022–2031 (USD Million)
Table 33   Global Mixers/Mixing Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 34   Global Incubators Market, by Country/Region, 2022–2031 (USD Million)
Table 35   Global Centrifuges Market, by Country/Region, 2022–2031 (USD Million)
Table 36   Global Shakers Market, by Country/Region, 2022–2031 (USD Million)
Table 37   Global Biosafety Cabinets Market, by Country/Region, 2022–2031 (USD Million)
Table 38   Global Other Consumables and Accessories Market, by Country/ Region, 2022–2031 (USD Million)
Table 39   Global Support Services Market for Biopharmaceutical Processing and Consumables, by Country/Region, 2022–2031 (USD Million)
Table 40   Global Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 41   Global Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 42   Global Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, Country/Region, 2022–2031 (USD Million)
Table 43   List of Monoclonal Antibodies Under Review in the U.S. and Europe
Table 44   Global Biopharmaceutical Processing Equipment and Consumables Market for Monoclonal Antibody Production, Country/Region, 2022–2031 (USD Million)
Table 45   Global Biopharmaceutical Processing Equipment and Consumables Market for Therapeutic Protein Production, Country/Region, 2022–2031 (USD Million)
Table 46   Global Biopharmaceutical Processing Equipment and Consumables Market for Vaccine Production, Country/Region, 2022–2031 (USD Million)
Table 47   Global Biopharmaceutical Processing Equipment and Consumables Market for Cell and Gene Therapy, Country/Region, 2022–2031 (USD Million)
Table 48   Global Biopharmaceutical Processing Equipment and Consumables Market for Research Bioproduction, Country/Region, 2022–2031 (USD Million)
Table 49   Global Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022-2031 (USD Million)
Table 50   Global Biopharmaceutical Processing Equipment and Consumables Market for Pharmaceutical & Biopharmaceutical Companies, by Country/Region, 2022-2031 (USD Million)
Table 51   Global Biopharmaceutical Processing Equipment and Consumables Market for CDMO, by Country/Region, 2022–2031 (USD Million)
Table 52   Global Biopharmaceutical Processing Equipment and Consumables Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 53   Global Biopharmaceutical Processing Equipment and Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 54   Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Country, 2022–2031 (USD Million)
Table 55   Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 56   Europe: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 57   Europe: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 58   Europe: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 59   Europe: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 60   Europe: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 61   Europe: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 62   Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 63   Europe: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 64   Europe: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 65   Germany: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 66   Germany: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 67   Germany: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 68   Germany: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 69   Germany: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 70   Germany: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 71   Germany: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 72   Germany: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 73   Germany: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 74   Germany: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 75   France: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 76   France: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 77   France: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 78   France: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 79   France: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 80   France: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 81   France: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 82   France: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 83   France: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 84   France: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 85   U.K.: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 86   U.K.: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 87   U.K.: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 88   U.K.: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 89   U.K.: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 90   U.K.: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 91   U.K.: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 92   U.K.: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 93   U.K.: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 94   U.K.: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 95   Italy: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 96   Italy: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 97   Italy: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 98   Italy: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 99   Italy: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 100   Italy: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 101   Italy: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 102   Italy: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 103   Italy: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 104   Italy: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 105   Spain: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 106   Spain: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 107   Spain: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 108   Spain: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 109   Spain: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 110   Spain: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 111   Spain: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 112   Spain: Biopharmaceutical Processing Equipment and Consumables Market, By Application, 2022–2031 (USD Million)
Table 113   Spain: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 114   Spain: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 115   Ireland: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 116   Ireland: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 117   Ireland: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 118   Ireland: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 119   Ireland: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 120   Ireland: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 121   Ireland: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 122   Ireland: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 123   Ireland: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 124   Ireland: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 125   Denmark: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 126   Denmark: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 127   Denmark: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 128   Denmark: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 129   Denmark: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 130   Denmark: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 131   Denmark: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 132   Denmark: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 133   Denmark: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 134   Denmark: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 135   Belgium: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 136   Belgium: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 137   Belgium: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 138   Belgium: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 139   Belgium: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 140   Belgium: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 141   Belgium: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 142   Belgium: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 143   Belgium: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 144   Belgium: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 145   Switzerland: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 146   Switzerland: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 147   Switzerland: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 148   Switzerland: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 149   Switzerland: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 150   Switzerland: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 151   Switzerland: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 152   Switzerland: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 153   Switzerland: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 154   Switzerland: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 155   Rest of Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 156   Rest of Europe: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 157   Rest of Europe: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 158   Rest of Europe: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 159   Rest of Europe: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 160   Rest of Europe: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 161   Rest of Europe: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 162   Rest of Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 163   Rest of Europe: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 164   Rest of Europe: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 165   North America: Biopharmaceutical Processing Equipment and Consumables Market, by Country, 2022–2031 (USD Million)
Table 166   North America: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 167   North America: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 168   North America: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 169   North America: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 170   North America: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 171   North America: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 172   North America: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 173   North America: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 174   North America: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 175   North America: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 176   U.S.: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 177   U.S.: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 178   U.S.: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 179   U.S.: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 180   U.S.: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 181   U.S.: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 182   U.S.: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 183   U.S.: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 184   U.S.: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 185   U.S.: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 186   Canada: Biopharmaceutical Processing Equipment and Consumables Market by Product Type, 2022–2031 (USD Million)
Table 187   Canada: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 188   Canada: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 189   Canada: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 190   Canada: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 191   Canada: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 192   Canada: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 193   Canada: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 194   Canada: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 195   Canada: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 196   Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 197   Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 198   Asia-Pacific: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 199   Asia-Pacific: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 200   Asia-Pacific: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 201   Asia-Pacific: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 202   Asia-Pacific: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 203   Asia-Pacific: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 204   Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 205   Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 206   Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 207   China: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 208   China: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 209   China: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 210   China: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 211   China: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 212   China: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 213   China: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 214   China: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 215   China: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 216   China: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 217   India: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 218   India: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 219   India: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 220   India: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 221   India: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 222   India: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 223   India: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 224   India: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 225   India: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 226   India: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 227   Japan: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 228   Japan: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 229   Japan: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 230   Japan: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 231   Japan: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 232   Japan: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 233   Japan: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 234   Japan: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 235   Japan: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 236   Japan: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 237   South Korea: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 238   South Korea: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 239   South Korea: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 240   South Korea: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 241   South Korea: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 242   South Korea: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 243   South Korea: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 244   South Korea: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 245   South Korea: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 246   South Korea: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 247   Rest of Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 248   Rest of Asia-Pacific: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 249   Rest of Asia-Pacific: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 250   Rest of Asia-Pacific: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 251   Rest of Asia-Pacific: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 252   Rest of Asia-Pacific: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 253   Rest of Asia-Pacific: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 254   Rest of Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 255   Rest of Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 256   Rest of Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 257   Latin America: Biopharmaceutical Processing Equipment and Consumables Market by Product Type, 2022–2031 (USD Million)
Table 258   Latin America: Chromatography Equipment and Consumables Market by Type, 2022–2031 (USD Million)
Table 259   Latin America: Bioreactors Market by Type, 2022–2031 (USD Million)
Table 260   Latin America: Cell Culture Products Market by Type, 2022–2031 (USD Million)
Table 261   Latin America: Cell Culture Media Market by Physical Form, 2022–2031 (USD Million)
Table 262   Latin America: Cell Culture Media Market by Type, 2022–2031 (USD Million)
Table 263   Latin America: Cell Culture Media Market by Source, 2022–2031 (USD Million)
Table 264   Latin America: Biopharmaceutical Processing Equipment and Consumables Market by Application, 2022–2031 (USD Million)
Table 265   Latin America: Biopharmaceutical Processing Equipment and Consumables Market Size for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 266   Latin America: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 267   Middle East & Africa: Biopharmaceutical Processing Equipment and Consumables Market by Product Type, 2022–2031 (USD Million)
Table 268   Middle East & Africa: Chromatography Equipment and Consumables Market by Type, 2022–2031 (USD Million)
Table 269   Middle East & Africa: Bioreactors Market by Type, 2022–2031 (USD Million)
Table 270   Middle East & Africa: Cell Culture Products Market by Type, 2022–2031 (USD Million)
Table 271   Middle East & Africa: Cell Culture Media Market by Physical Form, 2022–2031 (USD Million)
Table 272   Middle East & Africa: Cell Culture Media Market by Type, 2022–2031 (USD Million)
Table 273   Middle East & Africa: Cell Culture Media Market by Source, 2022–2031 (USD Million)
Table 274   Middle East & Africa: Biopharmaceutical Processing Equipment and Consumables Market by Application, 2022–2031 (USD Million)
Table 275   Middle East & Africa: Biopharmaceutical Processing Equipment and Consumables Market Size for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 276   Middle East & Africa: Biopharmaceutical Processing Equipment and Consumables Market by End User, 2022–2031 (USD Million)
Table 277   Recent Developments, by Company, 2021-2024

List of Figures
Figure 1   Research Process
Figure 2   Secondary Sources Referenced for this Study
Figure 3   Primary Research Techniques
Figure 4   Key Executives Interviewed
Figure 5   Breakdown of Primary Interviews (Supply-side & Demand side)
Figure 6   Market Sizing and Growth Forecast Approach
Figure 7   Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2024 Vs. 2031 (USD Million)
Figure 8   Global Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 9   Global Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 10   Biopharmaceutical Processing Equipment and Consumables Market, by Geography
Figure 11   Impact Analysis of Market Dynamics
Figure 12   Biopharmaceutical R&D Expenditure, 2015-2025 (USD Billion)
Figure 13   Porter's Five Forces Analysis
Figure 14   Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2024 Vs. 2031 (USD Million)
Figure 15   Number of Biologics Approved by the FDA Per Year (2018–2023)
Figure 16   Global Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 17   Global COVID-19 Vaccine Production Capacity, 2021–2023 (Doses in Billion)
Figure 18   Global Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 19   Global Biopharmaceutical Processing Equipment and Consumables Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 20   Europe: Biopharmaceutical Processing Equipment and Consumables Market Snapshot
Figure 21   France: Health Expenditure (USD Per Capita) 2017 Vs. 2019 Vs. 2021
Figure 22   Number of Biotech Firms in Italy 2018–2022
Figure 23   Belgium Pharmaceutical Production, 2018-2021 (USD Million)
Figure 24   North America: Biopharmaceutical Processing Equipment and Consumables Market Snapshot
Figure 25   Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market Snapshot
Figure 26   Key Growth Strategies Adopted by Leading Players, 2021-2024
Figure 27   Biopharmaceutical Processing Equipment and Consumables Market: Competitive Benchmarking (Part 1)
Figure 28   Biopharmaceutical Processing Equipment and Consumables Market: Competitive Benchmarking (Part 2)
Figure 29   Biopharmaceutical Processing Equipment and Consumables Market: Competitive Benchmarking, by Region
Figure 30   Competitive Dashboard: Biopharmaceutical Processing Equipment and Consumables Market
Figure 31   Market Share Analysis: Biopharmaceutical Processing Equipment and Consumables Industry, 2023
Figure 32   Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 33   Agilent Technologies, Inc.: Financial Snapshot (2023)
Figure 34   Sartorius AG: Financial Snapshot (2023)
Figure 35   Danaher Corporation: Financial Overview (2023)
Figure 36   Merck KGaA: Financial Overview (2023)
Figure 37   3M Company: Financial Snapshot (2023)
Figure 38   Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
Figure 39   Eppendorf SE: Financial Overview (2023)
Figure 40   Repligen Corporation: Financial Snapshot (2023)

Enquire

Check Discount

COVID-19

This report provides pre & post COVID-19 market estimates.

Download sample here

Processing & Packaging Technologies

Healthcare

This website is secure and we do not share your personal information with any third party. privacy policy

COVID-19

This report provides pre & post COVID-19 market estimates.

Request Sample

Customize My Report

Related Reports

Pharmaceutical Processing and Packaging Equipment Market - Global Opportunity Analysis and Industry Forecast (2024-2031)

Published Date: Aug-2024

Asia-Pacific Pharmaceutical Processing and Packaging Equipment Market - Opportunity Analysis and Industry Forecast (2024-2030)

Published Date: Jul-2024

Europe Biopharmaceutical Processing Equipment and Consumables Market - Opportunity Analysis and Industry Forecast (2024-2030)

Published Date: Jun-2024

Pharmaceutical Processing Equipment Market - Global Opportunity Analysis And Industry Forecast (2022-2029)

Published Date: Jun-2022

Tablet Processing and Packaging Equipment Market - Global Opportunity Analysis and Industry Forecast (2017-2022)

Published Date: Jun-2017

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031

The Biopharmaceutical Processing Equipment and Consumables Market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.

Biopharmaceutical Processing Equipment and Consumables Market Size & Forecast

Biopharmaceutical Processing Equipment and Consumables Market Growth Drivers

Growing Adoption of Single-use Bioprocessing Equipment for Commercial Production

Capacity Expansions of Biopharmaceutical Plants

Biopharmaceutical Processing Equipment and Consumables Market Trends

Growing Focus on Continuous Bioprocessing

Strong R&D Pipeline of Biopharmaceuticals

Biopharmaceutical Processing Equipment and Consumables Market Opportunities

Shift Towards Bioprocessing 4.0

Biopharmaceutical Processing Equipment and Consumables Market Analysis: Key Findings

By Product Type: In 2024, the Filtration Segment is Expected to Dominate the Biopharmaceutical Processing Equipment and Consumables Market

By Application: In 2024, the Commercial Bioproduction Segment is Expected to Dominate the Biopharmaceutical Processing Equipment and Consumables Market

By End User: In 2024, the Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Account for the Largest Share of the Biopharmaceutical Processing Equipment and Consumables Market

Biopharmaceutical Processing Equipment and Consumables Market Geographical Analysis

Key Companies

Biopharmaceutical Processing Equipment and Consumables Industry Overview: Latest Developments from Key Industry Players

Biopharmaceutical Processing Equipment and Consumables Market Research Summary

Key questions answered in the biopharmaceutical processing equipment and consumables market report:

The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.

Based on application, the commercial bioproduction segment is expected to grow at the highest CAGR over the forecast period. A large number of biopharmaceuticals in clinical development and nearing patent expirations of biologics are the key factors supporting the market growth.

Related Reports

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies